Stephen Whitehead is Chief Executive of the ABPI and is the chief advocate for the research-based industry in the UK. His career has centred on communications and policy and he is a regular speaker at industry and NHS conferences. Stephen has a strong personal passion and commitment to the pharmaceutical industry and has a vision for the future of healthcare based on patient-centred services and partnership with innovative industry.
Earlier in his career Stephen spent 10 years at GlaxoWellcome and Eli Lilly at UK, European and international level. In his last role, Stephen was Group Communications Director at Prudential PLC and prior to that he held leadership roles at Barclays PLC and Allied Domecq PLC.